RNA sequencing reveals differentially expressed genes as potential diagnostic and prognostic indicators of gallbladder carcinoma

Oncotarget

Volumn 6, Issue 24, 2015, Pages 20661-20671

  Gu, Xing ^a   Li, Bin ^a   Jiang, Mingming ^a   Fang, Meng ^a   Ji, Jun ^a   Wang, Aihua ^a   Wang, Mengmeng ^a   Jiang, Xiaoqing ^a   Gao, Chunfang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Biomarker; Oncogene; Oncology; Tumor suppressor; Tumorgenesis

Indexed keywords

ADULT; ARTICLE; BIRC5 GENE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE MARKER; DOWN REGULATION; DPT GENE; FBLNR5 GENE; FEMALE; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GLP2R GENE; HUMAN; HUMAN TISSUE; MALE; MMP9 GENE; OLFM4 GENE; ONCOGENE; RNA SEQUENCE; SMOC2 GENE; TK1 GENE; TNNT1 GENE; UPREGULATION; CARCINOGENESIS; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROGNOSIS; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

TUMOR MARKER;

BIOMARKERS, TUMOR; CARCINOGENESIS; FEMALE; GALLBLADDER NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MIDDLE AGED; ONCOGENES; PROGNOSIS; SEQUENCE ANALYSIS, RNA;

EID: 84940188993     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.3861     Document Type: Article

References (46)

1. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, Fraumeni JF Jr. Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer. 2007; 97:1577-1582.
2. Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012; 21:e183-191.
3. Stinton LM, Shaffer EA. Epidemiology of gallbladder disease: cholelithiasis and cancer. Gut Liver. 2012; 6:172-187.
4. Mishra K, Behari A, Kapoor VK, Khan MS, Prakash S, Agrawal S. Vascular endothelial growth factor single-nucleotide polymorphism in gall bladder cancer. J Gastroenterol Hepatol. 2013; 28:1678-1685.
5. Rai R, Sharma KL, Misra S, Kumar A, Mittal B. PSCA gene variants (rs2294008 and rs2978974) confer increased susceptibility of gallbladder carcinoma in females. Gene. 2013; 530:172-177.
6. Srivastava K, Srivastava A, Mittal B. Potential biomarkers in gallbladder cancer: present status and future directions. Biomarkers. 2013; 18:1-9.
7. Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin PC, Svensson MA, Kitabayashi N, Moss BJ, MacDonald TY, Cao X, Barrette T, Tewari AK, et al. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2011; 21:56-67.
8. Ho DW, Yang ZF, Yi K, Lam CT, Ng MN, Yu WC, Lau J, Wan T, Wang X, Yan Z, Liu H, Zhang Y, Fan ST. Gene expression profiling of liver cancer stem cells by RNA-sequencing. PLoS One. 2012; 7:e37159.
9. Beane J, Vick J, Schembri F, Anderlind C, Gower A, Campbell J, Luo L, Zhang XH, Xiao J, Alekseyev YO, Wang S, Levy S, Massion PP, et al. Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev Res (Phila). 2011; 4:803-817.
10. Shukla HS. Gallbladder cancer. J Surg Oncol. 2006; 93:604-606.
11. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997; 3:917-921.
12. Church DN, Talbot DC. Survivin in solid tumors: rationale for development of inhibitors. Curr Oncol Rep. 2012; 14:120-128.
13. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther. 2006; 5:1087-1098.
14. Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J. 2010; 430:199-205.
15. Nigam J, Chandra A, Kazmi HR, Parmar D, Singh D, Gupta V, M N. Expression of survivin mRNA in gallbladder cancer: a diagnostic and prognostic marker? Tumour Biol. 2014; 35:9241-9246.
16. He E, Xu XH, Guan H, Chen Y, Chen ZH, Pan ZL, Tang LL, Hu GZ, Li Y, Zhang M, Zhou J, Eriksson S, Fornander T, et al. Thymidine kinase 1 is a potential marker for prognosis and monitoring the response to treatment of patients with breast, lung, and esophageal cancer and non-Hodgkin's lymphoma. Nucleosides Nucleotides Nucleic Acids. 2010; 29:352-358.
17. Li Z, Wang Y, He J, Ma J, Zhao L, Chen H, Li N, Zhou J, He E, Skog S. Serological thymidine kinase 1 is a prognostic factor in oesophageal, cardial and lung carcinomas. Eur J Cancer Prev. 2010; 19:313-318.
18. Li Z, Wang Y, Ma J, He J, Zhou J, He E, Skog S. Transient increase in serum thymidine kinase 1 within one week after surgery of patients with carcinoma. Anticancer Res. 2010; 30:1295-1299.
19. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2:161-174.
20. Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013; 48:222-272.
21. Hu F, Ku MC, Markovic D, a Dzaye OD, Lehnardt S, Synowitz M, Wolf SA, Kettenmann H. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. Int J Cancer. 2014; 135:2569-2578.
22. Gao XH, Yang XQ, Wang BC, Liu SP, Wang FB. Overexpression of twist and matrix metalloproteinase-9 with metastasis and prognosis in gastric cancer. Asian Pac J Cancer Prev. 2013; 14:5055-5060.
23. Tomarev SI, Nakaya N. Olfactomedin domain-containing proteins: possible mechanisms of action and functions in normal development and pathology. Mol Neurobiol. 2009; 40:122-138.
24. Oue N, Sentani K, Noguchi T, Ohara S, Sakamoto N, Hayashi T, Anami K, Motoshita J, Ito M, Tanaka S, Yoshida K, Yasui W. Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients. Int J Cancer. 2009; 125:2383-2392.
25. Zhang X HQ, Yang Z, Li Y, Li CY. GW112, a novel antiapoptotic protein that promotes tumor growth. Cancer Res. 2004; 64:2474-2481.
26. Liu WL, Lee HW, Liu YQ, Wang RH, Rodgers GP. Olfactomedin 4 is a novel target gene of retinoic acids and 5-aza-2-deoxycytidine involved in human myeloid leukemia cell growth, differentiation, and apoptosis. Blood. 2010; 116:4938-4947.
27. Luo ZY, Zhang Q, Zhao ZS, Li B, Chen JF, Wang YY. OLFM4 is associated with lymph node metastasis and poor prognosis in patients with gastric cancer. J Cancer Res Clin. 2011; 137:1713-1720.
28. Verrier T, Solhonne B, Sallenave JM, Garcia-Verdugo I. The WAP protein Trappin-2/Elafin: a handyman in the regulation of inflammatory and immune responses. Int J Biochem Cell Biol. 2012; 44:1377-1380.
29. Saidi A, Javerzat S, Bellahcene A, De Vos J, Bello L, Castronovo V, Deprez M, Loiseau H, Bikfalvi A, HagedornM. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer. 2008; 122:2187-2198.
30. Labidi-Galy SI, Clauss A, Ng V, Duraisamy S, Elias KM, Piao HY, Bilal E, Davidowitz RA, Lu Y, Badalian-Very G, Gyorffy B, Kang UB, Ficarro S, et al. Elafin drives poor outcome in high-grade serous ovarian cancers and basal-like breast tumors. Oncogene. 2015; 34:373-383.
31. Hunt KK, Wingate H, Yokota T, Liu Y, Mills GB, Zhang F, Fang B, Su CH, Zhang M, Yi M, Keyomarsi K. Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res. 2013; 15:R3.
32. Money TT, King RG, Wong MH, Stevenson JL, Kalionis B, Erwich JJ, Huisman MA, Timmer A, Hiden U, Desoye G, Gude NM. Expression and cellular localisation of chloride intracellular channel 3 in human placenta and fetal membranes. Placenta. 2007; 28:429-436.
33. Qian Z, Okuhara D, Abe MK, Rosner MR. Molecular cloning and characterization of a mitogen-activated protein kinase-associated intracellular chloride channel. J Biol Chem. 1999; 274:1621-1627.
34. Dozynkiewicz MA, Jamieson NB, Macpherson I, Grindlay J, van den Berghe PV, von Thun A, Morton JP, Gourley C, Timpson P, Nixon C, McKay CJ, Carter R, Strachan D, et al. Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes/lysosomes and drive cancer progression. Dev Cell. 2012; 22:131-145.
35. Kee AJ, Hardeman EC. Tropomyosins in skeletal muscle diseases. Adv Exp Med Biol. 2008; 644:143-157.
36. Shand JA, Menown IB, McEneaney DJ. A timely diagnosis of myocardial infarction. Biomark Med. 2010; 4:385-393.
37. Moreno V, Hernandez-Romero D, Vilchez JA, Garcia-Honrubia A, Cambronero F, Casas T, Gonzalez J, Martinez P, Climent V, de la Morena G, Valdes M, Marin F. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail. 2010; 16:950-956.
38. Kratnov AE. Markers of inflammation and intracellular metabolism of neutrophils in patients with acute coronary syndrome and normal troponin T levels. Bull Exp Biol Med. 2011; 151:467-469.
39. Pinto JR, Gomes AV, Jones MA, Liang J, Nguyen S, Miller T, Parvatiyar MS, Potter JD. The functional properties of human slow skeletal troponin T isoforms in cardiac muscle regulation. J Biol Chem. 2012; 287:37362-37370.
40. Takeda U, Utani A, Wu J, Adachi E, Koseki H, Taniguchi M, Matsumoto T, Ohashi T, Sato M, Shinkai H. Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J Invest Dermatol. 2002; 119:678-683.
41. Kato A, Okamoto O, Ishikawa K, Sumiyoshi H, Matsuo N, Yoshioka H, Nomizu M, Shimada T, Fujiwara S. Dermatopontin interacts with fibronectin, promotes fibronectin fibril formation, and enhances cell adhesion. J Biol Chem. 2011; 286:14861-14869.
42. Takemoto S, Murakami T, Kusachi S, Iwabu A, Hirohata S, Nakamura K, Sezaki S, Havashi J, Suezawa C, Ninomiya Y, Tsuji T. Increased expression of dermatopontin mRNA in the infarct zone of experimentally induced myocardial infarction in rats: comparison with decorin and type I collagen mRNAs. Basic Res Cardiol. 2002; 97:461-468.
43. Okamoto O, Fujiwara S, Abe M, Sato Y. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity. Biochem J. 1999; 337:537-541.
44. Li X, Feng P, Ou J, Luo Z, Dai P, Wei D, Zhang C. Dermatopontin is expressed in human liver and is downregulated in hepatocellular carcinoma. Biochemistry (Mosc). 2009; 74:979-985.
45. Yamatoji M, Kasamatsu A, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K. Dermatopontin: a potential predictor for metastasis of human oral cancer. Int J Cancer. 2012; 130:2903-2911.
46. Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, Zhou D, Zhang D, Wang T, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014; 46:872-876.